Skip to main content
. 2019 Nov 14;9:16802. doi: 10.1038/s41598-019-53191-5

Figure 5.

Figure 5

Diagnostic efficacies of TIPRL, LC3, CD133 and the TIPRL/LC3/CD133 models in HCCs and early liver cancers. Diagnostic efficacies of TIPRL, LC3, CD133 and the combined models in HCCs (a,b) and grade1 liver cancers (c,d) were determined using ROC analysis. AUC, area under the curve.